Most importantly, younger women have increasingly been diagnosed with breast cancer, a significant risk factor for which was ...

Obesity is a known precursor to diabetes, hypertension, and cancer -- the non-communicable diseases rising significantly both ...

Popular weight-loss drug Wegovy maker Novo Nordisk expects high demand and acceptance for its anti-obesity drug, when ...

India is struggling with a rising tide of abdominal obesity, a health concern that is being driven primarily by unhealthy ...

So what is semaglutide and who uses it in India? Semaglutide belongs to the class of drugs called Glucagon-like peptide-1 ...

showed a high prevalence of abdominal obesity, while Jharkhand (23.9 percent) and Madhya Pradesh (24.9 percent) had lower ...

Breast cancer is becoming a significant public health issue in India, with rising incidents attributed to lifestyle changes, genetic factors, socio-ec ...

While all eyes are on the Indian industry – known for its ability to produce generic drugs at a fraction of the cost – to ...

Viking Therapeutics shares climbed 9% on Monday after the drug developer's oral obesity treatment helped reduce body weight ...

This study uncovers the hepatic vagal nerve's influence on circadian food intake, presenting new avenues for obesity treatment through targeted interventions.

Oct. 30, 2024 — Young people with severe obesity who underwent weight-loss surgery at age 19 or younger continued to see sustained weight loss and resolution of common obesity-related ...